Navigation Links
'Chemo Brain' After Breast Cancer Backed by Study

FRIDAY, Sept. 7 (HealthDay News) -- Breast cancer patients treated with chemotherapy are at risk for mild mental deficits known collectively as "chemo brain," a new study finds.

Researchers at the Moffitt Cancer Center in Tampa, Fla., reviewed existing research on brain function ("cognitive" functioning) in breast cancer patients who received standard doses of chemotherapy for at least six months.

The analysis revealed that, on average, these patients had mild impairments in verbal abilities (such as difficulty choosing words) and visual-spatial abilities (such as getting lost more easily).

Mental functioning varied among the patients, with some reporting no problems and others reporting more severe or widespread impairments, the investigators found.

The study was published online Aug. 27 in the Journal of Clinical Oncology.

"Breast cancer patients treated with chemotherapy who have subsequent cognitive deficits should be referred to a neuropsychologist for evaluation and management of the deficits," lead author Heather Jim, whose research focuses on the psychosocial and behavioral aspects of cancer survivorship, said in a Moffitt news release.

"Management usually involves developing an awareness of the situations in which their cognitive difficulties are likely to arise so that they can come up with strategies to compensate," she explained. "Research shows that such strategies can make a big difference in daily life when cognitive difficulties do arise."

More information

The American Cancer Society has more about chemo brain.

-- Robert Preidt

SOURCE: Moffitt Cancer Center, news release, Sept. 4, 2012

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Standard chemotherapy provides higher survival rate than experimental in lung cancer patients
2. Adding bavituximab to second-line chemotherapy doubles response rate
3. Review finds some evidence for chemo brain in breast cancer survivors, Moffitt Cancer Center says
4. More heart problems with 2 chemo drugs for breast cancer
5. Immunodeficient patients with secondary lung disease benefit from combined chemotherapy
6. Chemo During Pregnancy Doesnt Seem to Harm Newborn
7. Mechanisms of acquired chemoresistance in ovarian cancer identified
8. Breast cancer patients who lack RB gene respond better to neoadjuvant chemotherapy
9. Certain Heart Meds May Give Chemo a Boost
10. Specialized MRI scans assess value of anti-cancer chemotherapy long before tumors shown to shrink
11. RLIP76 contributes to pancreatic cancer cell resistance to chemotherapy and radiation
Post Your Comments:
Related Image:
'Chemo Brain' After Breast Cancer Backed by Study
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding emergency ... its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. Ogunleye ... M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. Ogunleye ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a method ... —Johnson is one of the first doctors to perform the treatment. Orthobiologics are ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Conventional wisdom ... of success. In terms of the latter, setting the bar too high can result ... more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... , ... Those who have experienced traumatic events may suffer from a complex ... as drug or alcohol abuse, as a coping mechanism. To avoid this pain and ... a traumatic event. , Trauma sufferers tend to feel a range of emotions, from ...
(Date:6/24/2016)... ... ... Marcy was in a crisis. Her son James, eight, was out of control. Prone to ... , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there ... my other children and say he was going to kill them. If we were ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016 The Academy of Managed Care Pharmacy ... that would allow biopharmaceutical companies to more easily share ... formulary and coverage decisions, a move that addresses the ... The recommendations address restrictions in the sharing ... drug label, a prohibition that hinders decision makers from ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
(Date:6/23/2016)... , June 23, 2016 Any dentist who ... challenges of the current process. Many of them do not ... the technical difficulties and high laboratory costs involved. And those ... offer it at such a high cost that the majority ... Dr. Parsa Zadeh , founder of Dental ...
Breaking Medicine Technology: